BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 8685049)

  • 1. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
    Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the regulation of prostatic oxytocin by gonadal steroids in the rat.
    Jenkin L; Nicholson HD
    J Androl; 1999; 20(1):80-7. PubMed ID: 10100477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
    Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
    Wright AS; Thomas LN; Douglas RC; Lazier CB; Rittmaster RS
    J Clin Invest; 1996 Dec; 98(11):2558-63. PubMed ID: 8958218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of finasteride on the rat ventral prostate.
    Shao TC; Kong A; Marafelia P; Cunningham GR
    J Androl; 1993; 14(2):79-86. PubMed ID: 8390428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antigonadotropic action of testosterone but not 7alpha-methyl-19-nortestosterone is attenuated through the 5alpha-reductase pathway in the castrated male rat pituitary gland.
    Bandivdekar AH; Karp R; Sundaram K; Kumar N
    J Androl; 2000; 21(2):268-75. PubMed ID: 10714822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of ventral prostate weight by finasteride is associated with suppression of insulin-like growth factor I (IGF-I) and IGF-I receptor genes and with an increase in IGF binding protein 3.
    Huynh H; Seyam RM; Brock GB
    Cancer Res; 1998 Jan; 58(2):215-8. PubMed ID: 9443394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.
    Prahalada S; Rhodes L; Grossman SJ; Heggan D; Keenan KP; Cukierski MA; Hoe CM; Berman C; van Zwieten MJ
    Prostate; 1998 May; 35(3):157-64. PubMed ID: 9582084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate.
    Ghatak S; Oliveria P; Kaplan P; Ho SM
    Prostate; 1996 Aug; 29(2):91-100. PubMed ID: 8700805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of microvessel densities in rat prostate tissues treated with finasteride, bicalutamide and surgical castration: a preliminary study.
    Kaya C; Ozyurek M; Turkeri LN
    Int J Urol; 2005 Feb; 12(2):194-8. PubMed ID: 15733115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
    Yatkin E; Bernoulli J; Talvitie EM; Santti R
    Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer.
    Shao TC; Li H; Ittmann M; Cunningham GR
    J Urol; 2007 Oct; 178(4 Pt 1):1521-7. PubMed ID: 17707058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
    Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
    J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a quantitative RT-PCR method to study 5alpha-reductase mRNA isozymes in rat prostate in different androgen status.
    Torres JM; Ruiz E; Ortega E
    Prostate; 2003 Jun; 56(1):74-9. PubMed ID: 12746849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 5-alpha-reductase activity induces stromal remodeling and smooth muscle de-differentiation in adult gerbil ventral prostate.
    Corradi LS; Góes RM; Carvalho HF; Taboga SR
    Differentiation; 2004 Jun; 72(5):198-208. PubMed ID: 15270776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of androgen deprivation on prostate alpha 1-adrenergic receptors.
    Lacey JP; Donatucci CF; Price DT; Page SO; Bennett SA; Tenniswood MP; Schwinn DA
    Urology; 1996 Aug; 48(2):335-41. PubMed ID: 8753753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.